GLP‑1 weight‑loss drugs started as diabetes medicines. Now they’re quietly becoming one of the most powerful tools in obesity treatment — and they’re still evolving. The science is advancing quickly. The harder question is whether access, cost, and policy will keep up.

Choosing where to set up in Europe is just the beginning. The real challenge — and the real competitive advantage — lies in finding, attracting, and retaining the right people in markets where the best talent has choices

Stepping away from a long career in life sciences executive research brought unexpected clarity. After years of working within established organisations, garden leave gave me the rare chance to pause and reflect on what I truly wanted from my professional life. The answer came quietly, while tending to my garden: I wanted to build something of my own. This post shares my journey from being an employee to launching Sharon Shields Consulting, a specialist consultancy focused on